RedHill Biopharma (RDHL) Gross Margin (2014 - 2023)
RedHill Biopharma (RDHL) reported Gross Margin of 55.12% for Q2 2023, up 415.0% year-over-year from 10.7% in Q2 2022, and little changed quarter-over-quarter from 55.21% in Q1 2023.
RedHill Biopharma (RDHL) Gross Margin (2014 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has 8 years of Gross Margin data on file, last reported at 55.12% in Q2 2023.
- Gross Margin for Q2 2023 came in at 55.12%, up 415.0% year-over-year; the trailing twelve-month figure through Jun 2023 was 42.74% (up 111.0% YoY), and the FY2025 annual result was 1927.62%, up 186732.0% from the prior year.
- Gross Margin held at 55.12% in Q2 2023 per RDHL's latest filing, from 55.21% in the prior quarter.
- Over five years, Gross Margin peaked at 75.99% in Q1 2019 and troughed at 62.41% in Q1 2020.
- A 5-year average of 43.77% and a median of 50.7% in 2020 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2020 and 2021: Gross Margin slumped 13840 bps in 2020, then soared 11257 bps in 2021.
- A 5-year view of Gross Margin shows it stood at 50.44% in 2019, then decreased by 0 bps to 50.37% in 2020, then tumbled by 75 bps to 12.4% in 2021, then soared by 165 bps to 32.82% in 2022, then soared by 68 bps to 55.12% in 2023.
- Business Quant data shows RDHL's Gross Margin at 55.12% in Q2 2023, 55.21% in Q1 2023, and 32.82% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -293.83% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 61.20% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 65.25% |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 55.12% |
| Mar 31, 2023 | 55.21% |
| Dec 31, 2022 | 32.82% |
| Sep 30, 2022 | 46.15% |
| Jun 30, 2022 | 50.97% |
| Mar 31, 2022 | 51.98% |
| Dec 31, 2021 | 12.40% |
| Sep 30, 2021 | 57.29% |
| Jun 30, 2021 | 50.75% |
| Mar 31, 2021 | 50.17% |
| Dec 31, 2020 | 50.37% |
| Sep 30, 2020 | 50.64% |
| Jun 30, 2020 | 32.11% |
| Mar 31, 2020 | -62.41% |
| Dec 31, 2019 | 50.44% |
| Sep 30, 2019 | 55.10% |
| Jun 30, 2019 | 72.81% |
| Mar 31, 2019 | 75.99% |
| Dec 31, 2018 | 57.03% |
| Sep 30, 2018 | 72.89% |